PITTSBURGH, PA and WOODBURY, MN / ACCESSWIRE / July 31, 2023 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide ...

Viatris and Kindeva Drug Delivery announced that Mylan, a Viatris subsidiary, has received the Food and Drug Administration's green light for Breyna, which is the first generic of AstraZeneca’s ...

Viatris announced the launch of Breyna ™ (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first generic version of AstraZeneca’s Symbicort ®. Breyna is a metered-dose inhaler ...

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...

Viatris’ generic Breyna could reach a large number of patients. The generic could generate $150 million in annual revenue for the company. Viatris’ shares today sell at an attractive valuation. This ...

PITTSBURGH, PA and WOODBURY, MN / ACCESSWIRE / July 31, 2023 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna (budesonide ...

Breyna is a branded-generic metered-dose inhaler that’s prescribed for chronic obstructive pulmonary disease (COPD) or asthma. The cost of Breyna, with and without insurance, can depend on several ...

The price you pay for Symbicort may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. You may be able to lower your long-term costs by getting a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

PITTSBURGH and WOODBURY, Minn., July 31, 2023 /3BL/ – Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and ...